Semaglutide Benefits
Reviewed by Fat Man in the Arena · Updated March 2026
How Semaglutide works
Semaglutide mimics the GLP-1 hormone, which is released after eating. It slows gastric emptying, reduces appetite by acting on brain regions that control hunger, and improves insulin sensitivity. The result is reduced caloric intake and improved metabolic markers.
Reported benefits
Based on published clinical trials, Semaglutide has been associated with the following benefits:
- Average 14.9% body weight loss over 68 weeks (STEP 1 trial)
- Reduced appetite and food cravings
- Improved cardiovascular risk factors
- Better blood sugar control
- Reduced waist circumference
- Oral formulation now available (Rybelsus / oral Wegovy)
Supporting research
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)
New England Journal of Medicine, 2021 · PMID: 33567185
Participants lost an average of 14.9% of body weight over 68 weeks compared to 2.4% with placebo. One-third of participants lost more than 20% of their body weight.
Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5)
Nature Medicine, 2022 · PMID: 35132148
Sustained weight loss of 15.2% at 104 weeks, demonstrating long-term efficacy when treatment is continued.
Important context
Benefits reported in clinical trials represent average outcomes across study populations. Individual results vary based on genetics, dosage, duration, and lifestyle factors.
Related peptides
Weekly peptide research updates
New studies, GLP-1 news, protocol insights, and weight loss data — delivered every week. Free. No spam.